Clinical Trial Update: Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis [NA]

View source ↗

Summary

A clinical trial studied daily use of Lipikar Balm AP from birth in infants at high risk of developing atopic dermatitis. The trial was terminated and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma
• Atopic Dermatitis
• Food Allergy

Drugs mentioned

• Lipikar Balm AP

Snippet

Sponsor: Cosmetique Active International | Conditions: Atopic Dermatitis, Eczema | NA | Status: TERMINATED | Results posted: 2016-02-24